Goodyear Tire & Rubber Co. Recognizes Dartmouth Cancer Center as GammaTile® Center of Excellence

Dartmouth Cancer Center Earns GammaTile® Center of Excellence Designation

GT Medical Technologies has recently designated Dartmouth Cancer Center as a GammaTile® Center of Excellence, acknowledging the center's outstanding leadership in patient care and proficiency in the innovative GammaTile procedure. This recognition is significant as it underscores the importance of advanced treatment options in the field of oncology, particularly for patients battling brain tumors. The GammaTile procedure represents a breakthrough in radiation therapy, allowing for immediate and targeted treatment during the surgical removal of tumors, which can enhance the overall effectiveness of the treatment and reduce the likelihood of tumor regrowth.

The GammaTile device, developed by GT Medical Technologies, is an FDA-cleared bioabsorbable collagen implant embedded with radiation seeds. It is designed specifically for patients with operable brain tumors, providing localized radiation therapy directly at the tumor site. By integrating radiation treatment during surgery, this method addresses cancer cells when they are at their most vulnerable, thereby eliminating the traditional gap between surgical intervention and subsequent radiation therapy. The approach not only maximizes treatment efficacy but also potentially improves patient outcomes by reducing recovery times and minimizing the chances of complications associated with delayed radiation treatments.

Dartmouth Cancer Center's achievement of this designation is a testament to the dedication and expertise of its medical team, including Dr. Linton Evans, Dr. Nathan Simmons, Dr. Greg Russo, Dr. Nupur Lala, and Dr. Tulika Ranjan. These physicians have successfully met rigorous clinical criteria and ongoing education requirements, ensuring that they remain at the forefront of advancements in brain tumor treatment. This milestone highlights the essential role that innovative technologies, such as GammaTile, play in enhancing care standards and addressing unmet patient needs in oncology.

In addition to this recognition, GT Medical Technologies continues to focus on developing solutions that elevate patient care in the medical field. The company's commitment to innovation reflects a broader trend within the healthcare industry, where technology-driven advancements are increasingly crucial for improving patient outcomes.

As the landscape of cancer treatment evolves, the partnership between medical institutions like Dartmouth Cancer Center and pioneering companies like GT Medical Technologies could lead to significant breakthroughs in how brain tumors are treated, ultimately benefiting countless patients and their families.